Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org
Gilberto Lopes: New Study Suggests Survival Benefit With GLP-1 RAs in Endometrial Cancer Oncodaily
Antibody-Drug Conjugate Improves Survival for Endometrial Cancer Patients Labroots
Endometriosis-associated pelvic pain represents a prototypical failure of systemic therapy for a locally organized, neuroinflammatory disease. Persistent pain arises from the convergence of estrogen-driven lesion survival, chronic inflammation, fibrosis, and …
Background: Endometriosis is traditionally conceptualized as a localized gynecological disorder characterized by the presence of ectopic endometrial tissue. However, high recurrence rates following apparently complete surgical excision challenge this lesion-based …
New therapy bests chemo to improve survival in endometrial cancer Rare Cancer News
Endometriosis, affecting 1 in 9 women, presents treatment and diagnostic challenges. To address these issues, we generated a comprehensive single-cell atlas of endometrial tissue, comprising 466,371 cells from 35 endometriosis …
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology